Allergy & Congestion
NDC Package 0536-1431-34

11-digit billing NDC: 00536143134

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Allergy & Congestion is do not divide, crush, chew or dissolve the tablet; swallow tablet whole adults and children 12 years of age and over take 1 tablet with a glass of water every 12 hours on an empty stomach; do not take more than 2 tablets in 24 hours children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctorOther informationsafety sealed: do not use if carton is opened or if individual blister units are torn or opened. store at 20-25°C (68-77°F).Meets USP dissolution test 7. Marketed by Rugby Laboratories, this product is identified by NDC 0536-1431 and is authorized under FDA application ANDA209116.

Identification & Billing

NDC Package Code
0536-1431-34
Package Description
2 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
00536143134

Clinical Specifications

Proprietary Name
Allergy & Congestion
Dosage Form
-
Usage Information
Do not divide, crush, chew or dissolve the tablet; swallow tablet whole adults and children 12 years of age and over take 1 tablet with a glass of water every 12 hours on an empty stomach; do not take more than 2 tablets in 24 hours children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctorOther informationsafety sealed: do not use if carton is opened or if individual blister units are torn or opened. store at 20-25°C (68-77°F).Meets USP dissolution test 7

Regulatory & Marketing

Labeler Name
Rugby Laboratories
FDA Application #
ANDA209116
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-17-2024
End Marketing Date
03-01-2026
Listing Expiration
03-01-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0536-1431). Click a package code to view its specific billing and regulatory data.

3 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0536-1431-34 identifies a specific commercial package of 2 blister pack in 1 carton / 10 tablet, film coated, extended release in 1 blister pack of Allergy & Congestion, labeled by Rugby Laboratories. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rugby Laboratories on May 17, 2024. The current certification is valid through March 01, 2026.

How is this Rugby Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00536143134. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0536-1431-34
11-Digit CMS (5-4-2)
00536-1431-34

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.